These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 10233835)

  • 1. High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma.
    Moch H; Schraml P; Bubendorf L; Mirlacher M; Kononen J; Gasser T; Mihatsch MJ; Kallioniemi OP; Sauter G
    Am J Pathol; 1999 Apr; 154(4):981-6. PubMed ID: 10233835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Identification of prognostic parameters for renal cell carcinoma by cDNA arrays and cell chips].
    Moch H; Schraml P; Bubendorf L; Mirlacher M; Kononen J; Gasser T; Mihatsch MJ; Kallioniemi OP; Sauter G
    Verh Dtsch Ges Pathol; 1999; 83():225-32. PubMed ID: 10714215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta defensin-1, parvalbumin, and vimentin: a panel of diagnostic immunohistochemical markers for renal tumors derived from gene expression profiling studies using cDNA microarrays.
    Young AN; de Oliveira Salles PG; Lim SD; Cohen C; Petros JA; Marshall FF; Neish AS; Amin MB
    Am J Surg Pathol; 2003 Feb; 27(2):199-205. PubMed ID: 12548166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Claudin-7 immunohistochemistry in renal tumors: a candidate marker for chromophobe renal cell carcinoma identified by gene expression profiling.
    Hornsby CD; Cohen C; Amin MB; Picken MM; Lawson D; Yin-Goen Q; Young AN
    Arch Pathol Lab Med; 2007 Oct; 131(10):1541-6. PubMed ID: 17922590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic biomarkers for renal cell carcinoma: selection using novel bioinformatics systems for microarray data analysis.
    Osunkoya AO; Yin-Goen Q; Phan JH; Moffitt RA; Stokes TH; Wang MD; Young AN
    Hum Pathol; 2009 Dec; 40(12):1671-8. PubMed ID: 19695674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression profiling of renal epithelial neoplasms: a method for tumor classification and discovery of diagnostic molecular markers.
    Young AN; Amin MB; Moreno CS; Lim SD; Cohen C; Petros JA; Marshall FF; Neish AS
    Am J Pathol; 2001 May; 158(5):1639-51. PubMed ID: 11337362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
    Rabjerg M
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic expression and single-nucleotide polymorphism profiling discriminates chromophobe renal cell carcinoma and oncocytoma.
    Tan MH; Wong CF; Tan HL; Yang XJ; Ditlev J; Matsuda D; Khoo SK; Sugimura J; Fujioka T; Furge KA; Kort E; Giraud S; Ferlicot S; Vielh P; Amsellem-Ouazana D; Debré B; Flam T; Thiounn N; Zerbib M; Benoît G; Droupy S; Molinié V; Vieillefond A; Tan PH; Richard S; Teh BT
    BMC Cancer; 2010 May; 10():196. PubMed ID: 20462447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas.
    Huo L; Sugimura J; Tretiakova MS; Patton KT; Gupta R; Popov B; Laskin WB; Yeldandi A; Teh BT; Yang XJ
    Hum Pathol; 2005 Mar; 36(3):262-8. PubMed ID: 15791570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microarray gene expression profiling and analysis in renal cell carcinoma.
    Liou LS; Shi T; Duan ZH; Sadhukhan P; Der SD; Novick AA; Hissong J; Skacel M; Almasan A; DiDonato JA
    BMC Urol; 2004 Jun; 4():9. PubMed ID: 15212686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular subclassification of kidney tumors and the discovery of new diagnostic markers.
    Takahashi M; Yang XJ; Sugimura J; Backdahl J; Tretiakova M; Qian CN; Gray SG; Knapp R; Anema J; Kahnoski R; Nicol D; Vogelzang NJ; Furge KA; Kanayama H; Kagawa S; Teh BT
    Oncogene; 2003 Oct; 22(43):6810-8. PubMed ID: 14555994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid and sensitive detection of messenger RNA expression for molecular differential diagnosis of renal cell carcinoma.
    Li G; Cuilleron M; Gentil-Perret A; Cottier M; Passebosc-Faure K; Lambert C; Genin C; Tostain J
    Clin Cancer Res; 2003 Dec; 9(17):6441-6. PubMed ID: 14695146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor suppressive microRNA‑138 contributes to cell migration and invasion through its targeting of vimentin in renal cell carcinoma.
    Yamasaki T; Seki N; Yamada Y; Yoshino H; Hidaka H; Chiyomaru T; Nohata N; Kinoshita T; Nakagawa M; Enokida H
    Int J Oncol; 2012 Sep; 41(3):805-17. PubMed ID: 22766839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of over-expressed genes in human renal cell carcinoma by combining suppression subtractive hybridization and cDNA library array.
    Ai J; Zhang Z; Xin D; Zhu H; Yan Q; Xin Z; Na Y; Guo Y
    Sci China C Life Sci; 2004 Apr; 47(2):148-57. PubMed ID: 15379247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue-wide expression profiling using cDNA subtraction and microarrays to identify tumor-specific genes.
    Amatschek S; Koenig U; Auer H; Steinlein P; Pacher M; Gruenfelder A; Dekan G; Vogl S; Kubista E; Heider KH; Stratowa C; Schreiber M; Sommergruber W
    Cancer Res; 2004 Feb; 64(3):844-56. PubMed ID: 14871811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide gene expression profiles of clear cell renal cell carcinoma: identification of molecular targets for treatment of renal cell carcinoma.
    Hirota E; Yan L; Tsunoda T; Ashida S; Fujime M; Shuin T; Miki T; Nakamura Y; Katagiri T
    Int J Oncol; 2006 Oct; 29(4):799-827. PubMed ID: 16964377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying CD82 (KAI1) as a marker for human chromophobe renal cell carcinoma.
    Yusenko MV; Kovacs G
    Histopathology; 2009 Dec; 55(6):687-95. PubMed ID: 20002769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanding the morphologic spectrum of chromophobe renal cell carcinoma: A study of 8 cases with papillary architecture.
    Michalova K; Tretiakova M; Pivovarcikova K; Alaghehbandan R; Perez Montiel D; Ulamec M; Osunkoya A; Trpkov K; Yuan G; Grossmann P; Sperga M; Ferak I; Rogala J; Mareckova J; Pitra T; Kolar J; Michal M; Hes O
    Ann Diagn Pathol; 2020 Feb; 44():151448. PubMed ID: 31918172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Useful markers for differential diagnosis of oncocytoma, chromophobe renal cell carcinoma and conventional renal cell carcinoma.
    Geramizadeh B; Ravanshad M; Rahsaz M
    Indian J Pathol Microbiol; 2008; 51(2):167-71. PubMed ID: 18603673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The G-protein-coupled receptor CLR is upregulated in an autocrine loop with adrenomedullin in clear cell renal cell carcinoma and associated with poor prognosis.
    Nikitenko LL; Leek R; Henderson S; Pillay N; Turley H; Generali D; Gunningham S; Morrin HR; Pellagatti A; Rees MC; Harris AL; Fox SB
    Clin Cancer Res; 2013 Oct; 19(20):5740-8. PubMed ID: 23969937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.